Article
Clinical experience with non‐invasive prenatal screening for single‐gene disorders
6 Aug 2021
Abstract excerpt
OBJECTIVE: To assess the performance of a non-invasive prenatal screening test (NIPT) for a panel of dominant single-gene disorders (SGD) with a combined population incidence of 1 in 600. METHODS: Cell-free fetal DNA isolated from maternal plasma samples accessioned from 14 April 2017 to 27 November 2019 was analyzed by next-generation sequencing, targeting 30 genes, to look for pathogenic or likely pathogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
